Published in Clin Exp Immunol on November 01, 1975
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol (1993) 1.06
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell Mol Immunol (2016) 0.77
The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat. Clin Exp Immunol (1979) 0.77
Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol (1972) 5.29
A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann N Y Acad Sci (1962) 3.68
Cyclophosphamide and urinary bladder toxicity. Cancer Res (1961) 2.20
DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE. Immunology (1964) 1.96
INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN. Cancer Res (1965) 1.83
Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77
Humoral antibodies in renal allotransplantation in man. N Engl J Med (1970) 1.74
[ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO]. Arzneimittelforschung (1963) 1.73
Use of cyclophosphamide in an attempt to modify the canine renal homograft response. Nature (1963) 1.72
SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDE. Transplantation (1964) 1.72
Effect of cyclophosphoramide, 6-mercaptopurine, actinomycin D and vincaleukoblastine on the acquisition of delayed hypersensitivity (DNCB) contact dermatitis) in the guinea-pig. J Invest Dermatol (1961) 1.23
Survival of homografts of the intestine with and without immunosuppression. Surgery (1966) 1.21
Arterial intimal thickening produced by alloantibody and xenoantibody. Transplantation (1973) 1.11
Analysis of growth and dose response curves. Biometrics (1969) 1.05
PROLONGATION OF CANINE RENAL HOMOGRAFT SURVIVAL BY ANTIMETABOLITES. Transplantation (1963) 0.92
Suppression of experimental allergic encephalomyelitis by cytotoxic drugs. Nature (1963) 0.90
Influence of cyclophosphamide on homograft rejection. JAMA (1965) 0.89
Single-dose toxicity of cyclophosphamide (NSC-26271) in dogs and monkeys. Cancer Chemother Rep 3 (1973) 0.87
Autologous bone marrow grafts in dogs treated with lethal doses of cyclophosphamide. Cancer Res (1969) 0.86
Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation (1969) 0.86
EXPERIMENTAL LUNG TRANSPLANTATION. Lancet (1964) 0.85
Immunosuppression with cyclophosphamide in dogs following cardiac transplantation. Transplant Proc (1973) 0.81
Continuing long-term remission after cyclophosphamide(NSC-26271) therapy for canine leukemia. Cancer Chemother Rep (1969) 0.79
Comparison of the efficacy of immunosuppressive regimens on orthotopic heart allografts. J Thorac Cardiovasc Surg (1974) 0.78
EFFECT OF CYCLOPHOSPHAMIDE IN THE ADRENALECTOMIZED ANIMAL. Surg Forum (1964) 0.78
DIURETIC ACTION OF CYCLOPHOSPHAMIDE IN EXPERIMENTAL ANIMALS. Med Bull (Ann Arbor) (1964) 0.78
Treatment of canine malignant lymphoma with surgery and chemotherapy. J Am Vet Med Assoc (1966) 0.78
Lipids of bile and intestinal synthesis of triglycerides. Fed Proc (1962) 0.78
CYCLOPHOSPHAMIDE THERAPY IN LYMPHOMA OF THE DOG. Cornell Vet (1963) 0.77
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26